Wolff Wiese Magana’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
PBBUPS
CAM
HP
AB
Wolff Wiese Magana's NBIX Position: Q2 2026 in Review
Wolff Wiese Magana held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 831 shares worth $140K. The position accounts for 0.06% of the portfolio, ranked #139.
Wolff Wiese Magana first reported a position in NBIX in Q4 2020 and has held it in 23 quarters since. 166 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.
- Wolff Wiese Magana held 831 shares of Neurocrine Biosciences worth $140K as of Q2 2026.
- Wolff Wiese Magana left its Neurocrine Biosciences share count unchanged in Q2 2026.
- Neurocrine Biosciences made up 0.06% of Wolff Wiese Magana's portfolio in Q2 2026, its #139 holding.
- Wolff Wiese Magana first reported a position in Neurocrine Biosciences in Q4 2020 and has held it in 23 quarters since.
- 166 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.
Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.